Canada markets closed

Ascletis Pharma Inc. (2VJ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1210-0.0010 (-0.82%)
At close: 03:29PM CEST
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-144,715
-144,715
-314,843
-199,017
-209,241
-
Depreciation & amortization
18,480
18,480
30,191
29,545
27,163
-
Stock based compensation
1,331
1,331
3,193
7,130
4,612
-
Change in working capital
34,452
34,452
33,807
-10,175
10,505
-
Inventory
-8,054
-8,054
-12,839
-5,068
-18,373
-
Other working capital
-163,320
-163,320
-216,865
-154,128
-123,871
-
Other non-cash items
-98,836
-98,836
-43,691
-21,950
-40,336
-
Net cash provided by operating activites
-144,162
-144,162
-202,464
-146,930
-84,911
-
Cash flows from investing activities
Investments in property, plant and equipment
-19,158
-19,158
-14,401
-7,198
-38,960
-
Acquisitions, net
-
-
-
0
-19,652
-67,400
Purchases of investments
-997,222
-997,222
-1,613,396
-601,978
-75,418
-
Sales/Maturities of investments
697,237
1,166,101
479,322
334,684
266,031
-
Net cash used for investing activites
149,845
149,845
-1,148,383
-274,492
132,297
-
Net change in cash
-75,813
-75,813
-1,352,266
-452,520
25,716
-
Cash at beginning of period
403,768
403,768
1,727,411
2,210,504
2,295,044
-
Cash at end of period
330,117
330,117
403,768
1,727,411
2,210,504
-
Free Cash Flow
Operating Cash Flow
-144,162
-144,162
-202,464
-146,930
-84,911
-
Capital Expenditure
-19,158
-19,158
-14,401
-7,198
-38,960
-
Free Cash Flow
-163,320
-163,320
-216,865
-154,128
-123,871
-